United States · 
Who invested in ProThera Biologics?
ProThera Biologics's investors include National Institutes of Health and Slater Technology Fund.
United States · Venture startup
Who invested in ProThera Biologics
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow ProThera Biologics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$750Kraised across 1 round since 2012, from 1 source
- Latest round
- Venture, $750KSept 2012
- Investors
- 2
The rounds
- Sept 2012
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about ProThera Biologics
How much has ProThera Biologics raised?
ProThera Biologics has raised $750K across 1 round since 2012.
When did ProThera Biologics last raise?
ProThera Biologics's most recent round was a Venture of $750K in Sept 2012.
What was ProThera Biologics's biggest round?
Its most recent round, $750K in Sept 2012, is also its largest on record.
Who backed ProThera Biologics first?
ProThera Biologics's first round on record, in Sept 2012, was backed by National Institutes of Health and Slater Technology Fund.
What stage is ProThera Biologics at?
ProThera Biologics's latest named round is a Venture, in Sept 2012.
Where is ProThera Biologics based?
ProThera Biologics is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.